Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

A better understanding of the anti-SARS-CoV-2 immune response is necessary to finely evaluate commercial serological assays but also to predict protection against reinfection and to help the development of vaccines. For this reason, we monitored the anti-SARS-CoV-2 antibody response in infected pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Microbiol
Autors principals: Brochot, Etienne, Demey, Baptiste, Touzé, Antoine, Belouzard, Sandrine, Dubuisson, Jean, Schmit, Jean-Luc, Duverlie, Gilles, Francois, Catherine, Castelain, Sandrine, Helle, Francois
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Microbiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604306/
https://ncbi.nlm.nih.gov/pubmed/33193227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.584251
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars